Clinical trialNCT03949855RecruitingPhase 2Interventional

Belimumab With Rituximab for Primary Membranous Nephropathy

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment58Membranous NephropathyNephrotic Syndrome

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Iñaki Sanz
Emory University, Department of Medicine, Division of Rheumatology
Study Chair
clinicaltrials.gov ↗
Patrick Nachman
University of Minnesota, Department of Medicine, Division of Renal Diseases and Hypertension
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama at Birmingham School of Medicine: Division of Nephrology
Birmingham, Alabama, United States
Dana Rizk
Recruiting
University of Arkansas
Little Rock, Arkansas, United States
Srilakshmi Ravula
Recruiting
University of California San Francisco
San Francisco, California, United States
Raymond Hsu
Recruiting
Stanford University School of Medicine: Division of Nephrology
Stanford, California, United States
Fahmeedah Kamal
Recruiting
the Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center:division of Nephrology and Hypertension
Torrance, California, United States
Sharon G. Adler
Recruiting
University of Colorado
Aurora, Colorado, United States
Amber Podoll, MD
Recruiting
Mayo Clinic Jacksonville: Department of Nephrology and Hypertension
Jacksonville, Florida, United States
Nabeel Aslam
Recruiting
University of Miami Miller School of Medicine, Div of Nephrology
Miami, Florida, United States
Jair Munoz Mendoza
Recruiting
Johns Hopkins
Baltimore, Maryland, United States
Duvuru Geetha
Recruiting
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Meryl A. Waldman
Recruiting
University of Michigan
Ann Arbor, Michigan, United States
Andrea Oliverio
Recruiting
University of Minnesota Health Clinical Research Unit
Minneapolis, Minnesota, United States
Patrick H. Nachman
Recruiting
Washington University in St. Louis
St Louis, Missouri, United States
Tinting Li
Recruiting
University of Nebraska
Omaha, Nebraska, United States
Prasanth Ravipati
Recruiting
Columbia University Medical Center: Division of Nephrology
New York, New York, United States
Andrew S. Bomback
Recruiting
University of North Carolina School of Medicine: Division of Nephrology and Hypertension, Kidney Center
Chapel Hill, North Carolina, United States
Vimal K. Derebail
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
John Sedor
Recruiting
Ohio State University Wexner Medical Center: Division of Nephrology
Columbus, Ohio, United States
Isabelle Ayoub
Recruiting
University of Pennsylvania: Department of Medicine: Renal-Electrolyte and Hypertension Division
Philadelphia, Pennsylvania, United States
Gaia Coppock
Recruiting
Providence Medical Research Center, Providence Health Care: Nephrology
Spokane, Washington, United States
Katherine R. Tuttle
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Mar 2020
Primary completion: 1 Mar 2029
Completion: 1 Mar 2030
Last update posted: 24 Jun 2026
Registered enrollment: 58
Registry id: NCT03949855

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.